Mutations in MDS - Prognostic and Therapeutic Implications | Aplastic Anemia & MDS International Foundation Return to top.

Mutations in MDS - Prognostic and Therapeutic Implications

Presenter(s): 
Topic(s): 
Myelodysplastic Syndromes (MDS)
Presentation Date: 
Wed, 04/17/2019 - 8:00pm (EDT)

Dr. Amer Zeidan from Yale Cancer Center explains the different mutations found in MDS and answers the question -“Should patients with MDS ask about their cancer mutations?” He discusses how mutations impact prognosis and affect treatment decisions

Share with addtoany.com.